» Articles » PMID: 21194378

Outside or Inside: Role of the Subcellular Localization of DP4-like Enzymes for Substrate Conversion and Inhibitor Effects

Overview
Journal Biol Chem
Specialty Biochemistry
Date 2011 Jan 4
PMID 21194378
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The discovery of the DP4-related enzymes DP8 and DP9 raised controversial discussion regarding the physiological and pathophysiological function of distinct members of the DP4 family. Particularly with regard to their potential relevance in regulating immune functions, it is of interest to know which role the subcellular distribution of the enzymes play. Synthetic substrates as well as low molecular weight inhibitors are widely used as tools, but little is yet known regarding their features in cell experiments, such as their plasma membrane penetration capacity. The fluorogenic substrates Gly-Pro-AMC or (Ala-Pro)₂-R110 predominantly detect plasma membrane-bound activities of viable cells (less than 0.1% of fluorochromes R110 or AMC inside viable cells after 1 h incubation). Additionally, the selective and non-selective DP8/9 inhibitors allo-Ile-isoindoline and Lys[Z(NO₂)]-pyrrolidide were found to be incapable of passing the plasma membrane easily. This suggests that previously reported cellular effects are not due to inhibition of the cytosolic enzymes DP8 or DP9. Moreover, our enzymatic studies with viable cells provided evidence that DP8 and/or DP9 are also present on the surface of immune cells under certain circumstances and could gain relevance particularly in the absence of DP4 expression. In summary, in cells which do express DP4 on the surface, this archetypical member of the DP4 family is the most relevant peptidase in the regulation of cellular functions.

Citing Articles

Time-Dependent Transcriptional Dynamics of Contextual Fear Memory Retrieval Reveals the Function of Dipeptidyl Peptidase 9 in Reconsolidation.

Guo W, Li W, Liu Y, Zhao Y, Xu L, Zhou Q Neurosci Bull. 2024; 41(1):16-32.

PMID: 39621238 PMC: 11748732. DOI: 10.1007/s12264-024-01324-w.


New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors.

Cui C, Tian X, Wei L, Wang Y, Wang K, Fu R Front Pharmacol. 2022; 13:1002871.

PMID: 36172198 PMC: 9510841. DOI: 10.3389/fphar.2022.1002871.


CD26 Deficiency Controls Macrophage Polarization Markers and Signal Transducers during Colitis Development and Resolution.

Vukelic I, Buljevic S, Baticic L, Barisic K, Franovic B, Detel D Int J Mol Sci. 2022; 23(10).

PMID: 35628317 PMC: 9141856. DOI: 10.3390/ijms23105506.


CCR2 and DPP9 expression in the peripheral blood of COVID-19 patients: Influences of the disease severity and gender.

Sharif-Zak M, Abbasi-Jorjandi M, Asadikaram G, Ghoreshi Z, Rezazadeh-Jabalbarzi M, Afsharipur A Immunobiology. 2022; 227(2):152184.

PMID: 35131543 PMC: 8806394. DOI: 10.1016/j.imbio.2022.152184.


Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins.

Wagner L, Klemann C, Stephan M, von Horsten S Clin Exp Immunol. 2015; 184(3):265-83.

PMID: 26671446 PMC: 4872383. DOI: 10.1111/cei.12757.